<DOC>
	<DOCNO>NCT01215890</DOCNO>
	<brief_summary>The occurrence bone loss Crohn 's disease patient important clinical problem patient without active disease . While therapy exist treatment prevention low BMD , evidence efficacy Crohn 's disease patient lack . The current standard therapy Canada treatment osteoporosis etidronate , adequate calcium vitamin D supplementation . The primary objective study assess efficacy risedronate , compare placebo , administer once-weekly , treatment low BMD spine hip patient Crohn 's disease 12 month , base intention-to-treat analysis .</brief_summary>
	<brief_title>Risedronate Therapy Treatment Low Bone Mineral Density Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Subjects 18 year age , old . Crohn 's disease , document clinical , radiologic , endoscopic histologic examination . Osteoporosis ( T score less 2.5 ) osteopenia ( T score 1.0 2.5 ) , determine dual energy Xray absorptiometry . Known bone disorder osteoporosis ( hyperparathyroidism , Paget 's disease , renal osteodystrophy document osteomalacia ) Abnormal thyroid function . Those patient thyroxine replacement must change dose two month prior prospective data collection program entry Clinically significant renal impairment ( serum creatinine â‰¥ 2x normal ) . Clinical Short Bowel Syndrome Patients total parenteral enteral nutrition Spinal anatomy would allow adequate assessment lateral spine use DEXA Patients receive : 1. previous bisphosphonate therapy 2. fluoride supplement 24 month prior entry 3. calcium supplement 1.0g/day 6 month prior entry 4. vitamin D supplement great 1000 IU/day 6 month prior entry 5. calcitonin 3 month prior entry Females hormone replacement therapy agree continue therapy duration prospective data collection program Men testosterone agree continue duration prospective data collection program Pregnancy woman breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>Low bone mineral density</keyword>
	<keyword>inflammatory bowel disease</keyword>
	<keyword>bisphosphonate</keyword>
</DOC>